Assessing the effect of extracorporeal treatments for lithium poisoning.

Lavergne, Valery; Ghannoum, Marc; Gosselin, Sophie; Goldfarb, David; Nolin, Thomas D; Dargan, Paul I; Roberts, Darren M

Lavergne, Valery; Ghannoum, Marc; Gosselin, Sophie; Goldfarb, David; Nolin, Thomas D; Dargan, Paul I; Roberts, Darren M.

Afiliación

Lavergne V; Department of Medicine, Sacré-Coeur Hospital, University of Montreal, Montreal, Canada.
Ghannoum M; Universite de Montreal Faculte de Medecine, Specialized Medicine, Montreal, Canada.
Gosselin S; Hôpital Charles-Lemoyne, Department of Emergency, Medicine, Montreal, Canada.
Goldfarb D; Nephrology Division, NYU Langone Health, New York, New York, USA.
Nolin TD; Nephrology Division, VA NY, Harbor Healthcare System Manhattan Campus, New York, New York, USA.
Dargan PI; Department of Pharmacy and Therapeutics, Center of Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
Roberts DM; General Medicine and Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, London, UK.

Br J Clin Pharmacol ; 87(1): 214-215, 2021 01.

Article en En | MEDLINE | ID: mdl-32501620

Asunto(s)

Antidepresivos; Litio; Humanos; Diálisis Renal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Litio / Antidepresivos Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google